Skip to main content
PMC home page
Philosophical Transactions of the Royal Society B: Biological Sciences logoLink to Philosophical Transactions of the Royal Society B: Biological Sciences
. 2000 Aug 29;355(1400):1051–1058. doi: 10.1098/rstb.2000.0642

Influence of follicular dendritic cells on HIV dynamics.

W S Hlavacek 1, N I Stilianakis 1, A S Perelson 1
PMCID: PMC1692815  PMID: 11186306

Abstract

In patients infected with human immunodeficiency virus type 1 (HIV-1), a large amount of virus is associated with follicular dendritic cells (FDCs) in lymphoid tissue. To assess the influence of FDCs on viral dynamics during antiretroviral therapy we have developed a mathematical model for treatment of HIV-1 infection that includes FDCs. Here, we use this model to analyse measurements of HIV-1 dynamics in the blood and lymphoid tissue of a representative patient, who was treated with a combination of HIV-1 reverse transcriptase and protease inhibitors. We show that loss of virus from FDCs during therapy can make a much larger contribution to plasma virus than production of virus by infected cells. This result challenges the notion that long-lived infected cells are a significant source of HIV-1 during drug therapy. Due to release of FDC-associated virus, we find that it is necessary to revise upward previous estimates of c, the rate at which free virus is cleared, and delta, the rate at which productively infected cells die. Furthermore, we find that potentially infectious virus, present before treatment, is released from FDCs during therapy and that the persistence of this virus can be affected by whether therapy includes reverse transcriptase inhibitors.

Full Text

The Full Text of this article is available as a PDF (280.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonhoeffer S., May R. M., Shaw G. M., Nowak M. A. Virus dynamics and drug therapy. Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6971–6976. doi: 10.1073/pnas.94.13.6971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burton G. F., Masuda A., Heath S. L., Smith B. A., Tew J. G., Szakal A. K. Follicular dendritic cells (FDC) in retroviral infection: host/pathogen perspectives. Immunol Rev. 1997 Apr;156:185–197. doi: 10.1111/j.1600-065x.1997.tb00968.x. [DOI] [PubMed] [Google Scholar]
  3. Cavert W., Notermans D. W., Staskus K., Wietgrefe S. W., Zupancic M., Gebhard K., Henry K., Zhang Z. Q., Mills R., McDade H. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science. 1997 May 9;276(5314):960–964. doi: 10.1126/science.276.5314.960. [DOI] [PubMed] [Google Scholar]
  4. Chun T. W., Carruth L., Finzi D., Shen X., DiGiuseppe J. A., Taylor H., Hermankova M., Chadwick K., Margolick J., Quinn T. C. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 1997 May 8;387(6629):183–188. doi: 10.1038/387183a0. [DOI] [PubMed] [Google Scholar]
  5. Chun T. W., Fauci A. S. Latent reservoirs of HIV: obstacles to the eradication of virus. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):10958–10961. doi: 10.1073/pnas.96.20.10958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. De Boer R. J., Perelson A. S. Target cell limited and immune control models of HIV infection: a comparison. J Theor Biol. 1998 Feb 7;190(3):201–214. doi: 10.1006/jtbi.1997.0548. [DOI] [PubMed] [Google Scholar]
  7. Finzi D., Siliciano R. F. Viral dynamics in HIV-1 infection. Cell. 1998 May 29;93(5):665–671. doi: 10.1016/s0092-8674(00)81427-0. [DOI] [PubMed] [Google Scholar]
  8. Goldstein B., Wofsy C. Why is it so hard to dissociate multivalent antigens from cell-surface antibodies? Immunol Today. 1996 Feb;17(2):77–80. doi: 10.1016/0167-5699(96)80583-4. [DOI] [PubMed] [Google Scholar]
  9. Haase A. T., Henry K., Zupancic M., Sedgewick G., Faust R. A., Melroe H., Cavert W., Gebhard K., Staskus K., Zhang Z. Q. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science. 1996 Nov 8;274(5289):985–989. doi: 10.1126/science.274.5289.985. [DOI] [PubMed] [Google Scholar]
  10. Haase A. T. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Annu Rev Immunol. 1999;17:625–656. doi: 10.1146/annurev.immunol.17.1.625. [DOI] [PubMed] [Google Scholar]
  11. Heath S. L., Tew J. G., Tew J. G., Szakal A. K., Burton G. F. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature. 1995 Oct 26;377(6551):740–744. doi: 10.1038/377740a0. [DOI] [PubMed] [Google Scholar]
  12. Igarashi T., Brown C., Azadegan A., Haigwood N., Dimitrov D., Martin M. A., Shibata R. Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma. Nat Med. 1999 Feb;5(2):211–216. doi: 10.1038/5576. [DOI] [PubMed] [Google Scholar]
  13. Joling P., Bakker L. J., Van Strijp J. A., Meerloo T., de Graaf L., Dekker M. E., Goudsmit J., Verhoef J., Schuurman H. J. Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent. J Immunol. 1993 Feb 1;150(3):1065–1073. [PubMed] [Google Scholar]
  14. Kim J., Wang Z., Gallagher D., Kotler D. P., Ma K., Heymsfield S. B. Extracellular water: sodium bromide dilution estimates compared with other markers in patients with acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr. 1999 Mar-Apr;23(2):61–66. doi: 10.1177/014860719902300261. [DOI] [PubMed] [Google Scholar]
  15. Liszewski M. K., Farries T. C., Lublin D. M., Rooney I. A., Atkinson J. P. Control of the complement system. Adv Immunol. 1996;61:201–283. doi: 10.1016/s0065-2776(08)60868-8. [DOI] [PubMed] [Google Scholar]
  16. Liu Y. J., Xu J., de Bouteiller O., Parham C. L., Grouard G., Djossou O., de Saint-Vis B., Lebecque S., Banchereau J., Moore K. W. Follicular dendritic cells specifically express the long CR2/CD21 isoform. J Exp Med. 1997 Jan 6;185(1):165–170. doi: 10.1084/jem.185.1.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mandel T. E., Phipps R. P., Abbot A., Tew J. G. The follicular dendritic cell: long term antigen retention during immunity. Immunol Rev. 1980;53:29–59. doi: 10.1111/j.1600-065x.1980.tb01039.x. [DOI] [PubMed] [Google Scholar]
  18. McLean A. R., Emery V. C., Webster A., Griffiths P. D. Population dynamics of HIV within an individual after treatment with zidovudine. AIDS. 1991 May;5(5):485–489. doi: 10.1097/00002030-199105000-00002. [DOI] [PubMed] [Google Scholar]
  19. Niyongabo T., Melchior J. C., Henzel D., Bouchaud O., Larouzé B. Comparison of methods for assessing nutritional status in HIV-infected adults. Nutrition. 1999 Oct;15(10):740–743. doi: 10.1016/s0899-9007(99)00146-x. [DOI] [PubMed] [Google Scholar]
  20. Notermans D. W., Goudsmit J., Danner S. A., de Wolf F., Perelson A. S., Mittler J. Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen. AIDS. 1998 Aug 20;12(12):1483–1490. doi: 10.1097/00002030-199812000-00010. [DOI] [PubMed] [Google Scholar]
  21. Notermans D. W., Jurriaans S., de Wolf F., Foudraine N. A., de Jong J. J., Cavert W., Schuwirth C. M., Kauffmann R. H., Meenhorst P. L., McDade H. Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group. AIDS. 1998 Jan 22;12(2):167–173. doi: 10.1097/00002030-199802000-00006. [DOI] [PubMed] [Google Scholar]
  22. Nowak M. A., Bangham C. R. Population dynamics of immune responses to persistent viruses. Science. 1996 Apr 5;272(5258):74–79. doi: 10.1126/science.272.5258.74. [DOI] [PubMed] [Google Scholar]
  23. Orenstein J. M., Feinberg M., Yoder C., Schrager L., Mican J. M., Schwartzentruber D. J., Davey R. T., Jr, Walker R. E., Falloon J., Kovacs J. A. Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient. AIDS. 1999 Nov 12;13(16):2219–2229. doi: 10.1097/00002030-199911120-00004. [DOI] [PubMed] [Google Scholar]
  24. Pantaleo G., Graziosi C., Demarest J. F., Cohen O. J., Vaccarezza M., Gantt K., Muro-Cacho C., Fauci A. S. Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection. Immunol Rev. 1994 Aug;140:105–130. doi: 10.1111/j.1600-065x.1994.tb00867.x. [DOI] [PubMed] [Google Scholar]
  25. Perelson A. S., Essunger P., Cao Y., Vesanen M., Hurley A., Saksela K., Markowitz M., Ho D. D. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature. 1997 May 8;387(6629):188–191. doi: 10.1038/387188a0. [DOI] [PubMed] [Google Scholar]
  26. Perelson A. S., Neumann A. U., Markowitz M., Leonard J. M., Ho D. D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 1996 Mar 15;271(5255):1582–1586. doi: 10.1126/science.271.5255.1582. [DOI] [PubMed] [Google Scholar]
  27. Ramratnam B., Bonhoeffer S., Binley J., Hurley A., Zhang L., Mittler J. E., Markowitz M., Moore J. P., Perelson A. S., Ho D. D. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet. 1999 Nov 20;354(9192):1782–1785. doi: 10.1016/S0140-6736(99)02035-8. [DOI] [PubMed] [Google Scholar]
  28. Reynes M., Aubert J. P., Cohen J. H., Audouin J., Tricottet V., Diebold J., Kazatchkine M. D. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J Immunol. 1985 Oct;135(4):2687–2694. [PubMed] [Google Scholar]
  29. Ross G. D., Medof M. E. Membrane complement receptors specific for bound fragments of C3. Adv Immunol. 1985;37:217–267. doi: 10.1016/s0065-2776(08)60341-7. [DOI] [PubMed] [Google Scholar]
  30. Sachsenberg N., Perelson A. S., Yerly S., Schockmel G. A., Leduc D., Hirschel B., Perrin L. Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med. 1998 Apr 20;187(8):1295–1303. doi: 10.1084/jem.187.8.1295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Schacker T., Little S., Connick E., Gebhard-Mitchell K., Zhang Z. Q., Krieger J., Pryor J., Havlir D., Wong J. K., Richman D. Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy. J Infect Dis. 2000 Jan;181(1):354–357. doi: 10.1086/315178. [DOI] [PubMed] [Google Scholar]
  32. Schmitz J., van Lunzen J., Tenner-Racz K., Grossschupff G., Racz P., Schmitz H., Dietrich M., Hufert F. T. Follicular dendritic cells retain HIV-1 particles on their plasma membrane, but are not productively infected in asymptomatic patients with follicular hyperplasia. J Immunol. 1994 Aug 1;153(3):1352–1359. [PubMed] [Google Scholar]
  33. Stellbrink H. J., van Lunzen J., Hufert F. T., Fröschle G., Wolf-Vorbeck G., Zöllner B., Albrecht H., Greten H., Racz P., Tenner-Racz K. Asymptomatic HIV infection is characterized by rapid turnover of HIV RNA in plasma and lymph nodes but not of latently infected lymph-node CD4+ T cells. AIDS. 1997 Jul 15;11(9):1103–1110. doi: 10.1097/00002030-199709000-00004. [DOI] [PubMed] [Google Scholar]
  34. Stoiber H., Clivio A., Dierich M. P. Role of complement in HIV infection. Annu Rev Immunol. 1997;15:649–674. doi: 10.1146/annurev.immunol.15.1.649. [DOI] [PubMed] [Google Scholar]
  35. Szakal A. K., Kosco M. H., Tew J. G. A novel in vivo follicular dendritic cell-dependent iccosome-mediated mechanism for delivery of antigen to antigen-processing cells. J Immunol. 1988 Jan 15;140(2):341–353. [PubMed] [Google Scholar]
  36. Tenner-Racz K., Stellbrink H. J., van Lunzen J., Schneider C., Jacobs J. P., Raschdorff B., Grosschupff G., Steinman R. M., Racz P. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J Exp Med. 1998 Mar 16;187(6):949–959. doi: 10.1084/jem.187.6.949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wickham T. J., Granados R. R., Wood H. A., Hammer D. A., Shuler M. L. General analysis of receptor-mediated viral attachment to cell surfaces. Biophys J. 1990 Dec;58(6):1501–1516. doi: 10.1016/S0006-3495(90)82495-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wong J. K., Günthard H. F., Havlir D. V., Zhang Z. Q., Haase A. T., Ignacio C. C., Kwok S., Emini E., Richman D. D. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12574–12579. doi: 10.1073/pnas.94.23.12574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Yamakawa M., Imai Y. Complement activation in the follicular light zone of human lymphoid tissues. Immunology. 1992 Jul;76(3):378–384. [PMC free article] [PubMed] [Google Scholar]
  40. Zhang L., Dailey P. J., He T., Gettie A., Bonhoeffer S., Perelson A. S., Ho D. D. Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques. J Virol. 1999 Jan;73(1):855–860. doi: 10.1128/jvi.73.1.855-860.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Philosophical Transactions of the Royal Society B: Biological Sciences are provided here courtesy of The Royal Society

RESOURCES